IRIS
IMBERTI, Davide
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.747
AS - Asia 1.360
EU - Europa 408
SA - Sud America 218
Continente sconosciuto - Info sul continente non disponibili 124
AF - Africa 57
OC - Oceania 2
Totale 3.916
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.664
SG - Singapore 484
BD - Bangladesh 307
VN - Vietnam 260
IT - Italia 208
BR - Brasile 134
FR - Francia 110
CN - Cina 91
IN - India 42
HK - Hong Kong 41
CA - Canada 33
AR - Argentina 26
IQ - Iraq 22
ZA - Sudafrica 20
GB - Regno Unito 17
EC - Ecuador 15
PH - Filippine 14
ID - Indonesia 13
MX - Messico 13
VE - Venezuela 13
CO - Colombia 12
TR - Turchia 12
IE - Irlanda 11
PK - Pakistan 11
DE - Germania 10
RU - Federazione Russa 10
MA - Marocco 9
SA - Arabia Saudita 9
CL - Cile 8
JM - Giamaica 8
MY - Malesia 8
NL - Olanda 8
ES - Italia 7
PL - Polonia 7
CR - Costa Rica 6
SC - Seychelles 6
UZ - Uzbekistan 6
EG - Egitto 5
JP - Giappone 5
KE - Kenya 5
TH - Thailandia 5
AT - Austria 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
JO - Giordania 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
ET - Etiopia 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
BB - Barbados 2
HN - Honduras 2
IL - Israele 2
LT - Lituania 2
LU - Lussemburgo 2
OM - Oman 2
SE - Svezia 2
SV - El Salvador 2
TW - Taiwan 2
UA - Ucraina 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TJ - Tagikistan 1
TN - Tunisia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 3.792
Salva come PNG Salva come JPEG
Città #
San Jose 505
Council Bluffs 263
Singapore 187
Ashburn 117
Lauterbourg 104
Ho Chi Minh City 86
Boardman 73
Hanoi 68
New York 68
Los Angeles 57
Santa Clara 51
Buffalo 50
Rome 32
Hong Kong 28
Milan 24
Baghdad 12
Dallas 12
Dublin 11
Naples 11
Denver 9
Johannesburg 9
Orem 9
Turin 9
Bologna 7
Charlotte 7
Guayaquil 7
Phoenix 7
Toronto 7
Caracas 6
Catania 6
Haiphong 6
Kingston 6
Santa Ana 6
São Paulo 6
Warsaw 6
Atlanta 5
Brasília 5
Brooklyn 5
Chicago 5
Da Nang 5
Durban 5
Fayetteville 5
Karbala 5
Nuremberg 5
Palermo 5
Philadelphia 5
Princeton 5
Quito 5
Tashkent 5
Austin 4
Baku 4
Bari 4
Biên Hòa 4
Cairo 4
Canton 4
Casablanca 4
Honolulu 4
Lahore 4
Manchester 4
Manila 4
Medellín 4
Raleigh 4
Rio de Janeiro 4
St Louis 4
Tây Ninh 4
Williamsburg 4
Alexandria 3
Bogotá 3
Curitiba 3
Detroit 3
Florence 3
Fortaleza 3
Guangzhou 3
Guatemala City 3
Houston 3
Hyderabad 3
Hải Dương 3
Istanbul 3
Jacksonville 3
Jaipur 3
Jeddah 3
Jinan 3
Kenitra 3
Kuala Lumpur 3
Managua 3
Mexicali 3
Mexico City 3
Mocksville 3
Mumbai 3
Nairobi 3
Pasadena 3
Passo Fundo 3
Queens 3
Riyadh 3
Sacramento 3
Salvador 3
San Francisco 3
San José 3
Santiago 3
Shanghai 3
Totale 2.112
Salva come PNG Salva come JPEG
Nome #
Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 110
Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 92
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 68
"Timing" of arrival and in-hospital mortality in a cohort of patients under anticoagulant therapy presenting to the emergency departments with cerebral hemorrhage: A multicenter chronobiological study in Italy 67
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 65
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 63
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 61
Low-Molecular-Weight Heparins: Before or After Surgery? New Concepts and Evidence Congress Report from the SIGMA TAU/ROVI Satellite Symposium (Rome, Italy, 13 November 2006) 57
An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study 55
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery 55
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 53
Factors associated with the timing of diagnosis of venous thromboembolism: Results from the MASTER registry 50
A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum) 49
Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature 49
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in at-risk patient groups: pregnancy, elderly and obese patients 49
D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism 48
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 47
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain 45
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 44
Extended oral anticoagulant therapy after a first episode of pulmonary embolism 43
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms 43
The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial 42
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 42
Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage 42
Management Strategies for Vitamin K Antagonists Reversal in Patients With Major Bleeding: A Survey of Italian Emergency Departments 42
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study 39
Epidemiology and risk factors of venous thromboembolism 39
Clinical management of rivaroxaban-treated patients 39
Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia 39
Successful Protein C Concentrate Administration during Initiation of Oral Anticoagulation in Adult Patients with Severe Congenital Protein C Deficiency: Report of Two Cases 38
A survey of thromboprophylaxis management in patients with major trauma 37
Retrievable vena cava filters: a review 37
Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage 37
Higher mortality rate in patients hospitalised for acute pulmonary embolism during weekends 37
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 36
Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial 35
Seasonal and Weekly Patterns of Occurrence of Acute Cardiovascular Diseases: Does a Gender Difference Exist? 35
Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban 34
Higher mortality in patients hospitalized for acute aortic rupture or dissection during weekends 34
Prophylaxis of Venous Thromboembolism with Low Molecular Weight Heparin in Bariatric Surgery: a Prospective, Randomised Pilot Study Evaluating Two Doses of Parnaparin (BAFLUX Study) 34
A commentary: To screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry 34
Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review 33
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study 33
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum) 33
Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 32
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 32
A survey of thrombosis prophylaxis use in patients with lower limb fractures 32
Prophylaxis of venous thromboembolism in bariatric surgery: A prospective randomized study comparing two doses of parnaparin 32
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy 32
Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update 31
Venous thromboembolism after major orthopaedic surgery: a population-based cohort study 31
A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism 31
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding 31
Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review 31
Retrievable vena cava filters: a clinical review 31
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery 31
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 30
Retrievable vena cava filters: clinical experience 30
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients 29
Management of primary care patients with suspected deep vein thrombosis use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation 28
Inferior vena cava filters: use or abuse? 28
The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry 28
Pharmacodynamics of low molecular weight heparin in patients undergoing bariatric surgery: A prospective, randomised study comparing two doses of parnaparin (BAFLUX STUDY) 28
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists A meta-analysis 27
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 27
EXTENDED PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS UNDERGOING MAJOR ORTHOPAEDIC SURGERY IN ITALY: A PHARMACOECONOMIC STUDY 27
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury A prospective cohort study 26
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment 26
Interventional Approaches in VTE Treatment (Vena Cava Filters, Catheter-Guided Thrombolysis, Thrombosuction) 26
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 26
SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature 25
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2 25
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis 25
Effectiveness of recombinant factor VIIa in haemorragic cancer-related disseminated intravascular coagulation: a case report 24
The MASTER registry on venous thromboembolism: Description of the study cohort 24
Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution 24
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 24
Retrievable vena cava filters: Key considerations 24
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study 24
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism 24
Venous thromboembolism in patients undergoing shoulder surgery: findings from the Recos registry 23
Prognostic relevance of asymptomatic venous thromboembolism in patients with cancer 23
Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism 22
Interventional treatment of venous thromboembolism: A review 22
Primary prophylaxis of VTE in cancer outpatients 22
Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered 22
The Optimal Duration of Anticoagulant Therapy In patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study) 22
Evaluation of unmet clinical needs in prophylaxis and treatment of venous thromboembolism in high-risk patient groups: cancer and critically ill 22
Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes 22
The practical management of NAO 22
Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis 22
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal 22
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study 22
Venous thromboembolism prophylaxis in medical patients: Future perspectives 22
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 21
Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope 21
Long term clinical outcomes of cancer associated venous thromboembolism: findings from the MASTER registry 21
Venous thromboembolism in patients undergoing shoulder surgery: Findings from the RECOS Registry 21
Real-Life Management of Venous Thromboembolism With Rivaroxaban: Results From EXperience VTE, an Italian Epidemiological Survey 21
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 21
Totale 3.506
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.613
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20245 0 0 0 0 3 0 0 0 0 1 1 0
2024/202583 0 3 24 0 6 6 3 1 8 8 4 20
2025/20263.001 12 22 27 251 349 252 323 107 656 267 424 311
2026/2027827 348 266 213 0 0 0 0 0 0 0 0 0
Totale 3.916